End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.5 DKK | +5.00% | +5.63% | -40.85% |
Apr. 16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
Apr. 12 | Curasight A/S Announces Board Changes | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CURASIGHT A/S | Other Biotechnology & Medical Research | +5.00% | +5.63% | -40.85% | -40.00% | - | 30.15M | - | - | - |
- Stock Market
- Equities
- CURAS Stock
- Charts Curasight A/S
- Relative Strength Chart